Nicola Wealth Management LTD. cut its position in Itron, Inc. (NASDAQ:ITRI - Free Report) by 20.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,000 shares of the scientific and technical instruments company's stock after selling 6,000 shares during the period. Nicola Wealth Management LTD. owned 0.05% of Itron worth $2,514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently made changes to their positions in ITRI. Wayfinding Financial LLC acquired a new stake in shares of Itron in the first quarter worth approximately $45,000. Quarry LP boosted its stake in Itron by 155.6% during the first quarter. Quarry LP now owns 910 shares of the scientific and technical instruments company's stock worth $95,000 after buying an additional 554 shares during the last quarter. Contravisory Investment Management Inc. boosted its stake in Itron by 98.0% during the first quarter. Contravisory Investment Management Inc. now owns 1,711 shares of the scientific and technical instruments company's stock worth $179,000 after buying an additional 847 shares during the last quarter. Captrust Financial Advisors boosted its stake in Itron by 6.3% during the fourth quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock worth $233,000 after buying an additional 128 shares during the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC boosted its stake in Itron by 7.3% during the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,345 shares of the scientific and technical instruments company's stock worth $246,000 after buying an additional 160 shares during the last quarter. 96.19% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have weighed in on ITRI. Guggenheim reissued a "buy" rating and set a $155.00 price objective (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Roth Capital boosted their price objective on Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. Stephens set a $130.00 price objective on Itron in a research note on Monday, August 4th. JPMorgan Chase & Co. upgraded Itron from a "neutral" rating to an "overweight" rating and lifted their target price for the company from $128.00 to $145.00 in a research report on Thursday, July 31st. Finally, Johnson Rice downgraded Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Ten equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $136.55.
View Our Latest Report on ITRI
Insider Activity at Itron
In other Itron news, SVP Justin K. Patrick sold 388 shares of the company's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $48,620.28. Following the sale, the senior vice president owned 20,761 shares in the company, valued at $2,601,560.91. This represents a 1.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP John F. Marcolini sold 565 shares of the company's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the sale, the senior vice president owned 14,396 shares in the company, valued at approximately $1,803,962.76. This trade represents a 3.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 3,037 shares of company stock worth $380,566 over the last quarter. 1.45% of the stock is currently owned by insiders.
Itron Trading Up 0.5%
Shares of ITRI stock traded up $0.63 on Monday, hitting $120.17. The stock had a trading volume of 430,032 shares, compared to its average volume of 595,168. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75. The firm has a market capitalization of $5.49 billion, a P/E ratio of 20.54, a P/E/G ratio of 0.66 and a beta of 1.46. Itron, Inc. has a 1 year low of $90.11 and a 1 year high of $140.04. The company's 50 day moving average price is $127.60 and its 200-day moving average price is $117.63.
Itron (NASDAQ:ITRI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.29. The firm had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company's quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current year.
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Further Reading

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.